APA

Blazar B. R., Taylor P. A., Panoskaltsis-Mortari A. & Vallera D. A. (19980611). Rapamycin inhibits the generation of graft-versus-host disease- and graft-versus-leukemia-causing T cells by interfering with the production of Th1 or Th1 cytotoxic cytokines. : Journal of immunology (Baltimore, Md. : 1950).

Chicago

Blazar B R, Taylor P A, Panoskaltsis-Mortari A and Vallera D A. 19980611. Rapamycin inhibits the generation of graft-versus-host disease- and graft-versus-leukemia-causing T cells by interfering with the production of Th1 or Th1 cytotoxic cytokines. : Journal of immunology (Baltimore, Md. : 1950).

Harvard

Blazar B. R., Taylor P. A., Panoskaltsis-Mortari A. and Vallera D. A. (19980611). Rapamycin inhibits the generation of graft-versus-host disease- and graft-versus-leukemia-causing T cells by interfering with the production of Th1 or Th1 cytotoxic cytokines. : Journal of immunology (Baltimore, Md. : 1950).

MLA

Blazar B R, Taylor P A, Panoskaltsis-Mortari A and Vallera D A. Rapamycin inhibits the generation of graft-versus-host disease- and graft-versus-leukemia-causing T cells by interfering with the production of Th1 or Th1 cytotoxic cytokines. : Journal of immunology (Baltimore, Md. : 1950). 19980611.